Compare Noble Corporation plc (NE) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Noble Corporation plc vs TransMedics Group Inc — how do they compare? Noble Corporation plc trades at $42.53 (market cap $6.48B), while TransMedics Group Inc trades at $73.5 (market cap $2.54B). The key difference: Noble Corporation plc is far larger — about 2.6× TransMedics Group Inc's market cap, and Noble Corporation plc pays a 4.93% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| NE | TMDX | |
|---|---|---|
Market Cap | $6.48B | $2.54B |
Sector | Technology | Technology |
52-Week High | $54.37 | $150.42 |
52-Week Low | $25.70 | $61.99 |
Enterprise Value | $7.73B | $2.94B |
Dividend Yield | 4.93% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Noble Corporation (NE) trades at $40.60, down 2.17% on the day, with a neutral technical signal. The company reported mixed Q1 2026 earnings, beating expectations, but missed in the prior two quarters. Recent news highlights new offshore drilling contracts, including a $136.2 million Brunei deal, and the upcoming Q2 2026 earnings report on July 27, 2026. Positive cash flow and a dividend payment of $0.50 per share in June 2026 support shareholder returns.
The outlook is cautiously optimistic, supported by new contracts and a consensus price target of $49.75, implying potential upside. Risks include execution on earnings expectations and offshore drilling market volatility. Analyst sentiment is mixed, with 31% Buy ratings, but the stock's current price is near the low end of the target range, suggesting a balanced risk-reward profile.
TransMedics (TMDX) is trading at $73.47, down 0.69% on the day, amid a mixed technical and fundamental backdrop. The stock shows neutral technical signals with support near $72 and resistance at $75, while fundamentals are strong with a trailing P/E of 16.81 and robust profitability metrics like a 27.04% net income margin. Recent earnings saw a Q1 2026 miss but beats in prior quarters, and the company is expanding in Europe through strategic investments.
The outlook is cautiously optimistic with a consensus price target of $108.71 implying significant upside, supported by 75% analyst buy ratings. Key risks include margin pressure from expansion costs and competitive threats, but the company's organ transplant logistics network offers a durable competitive advantage for long-term growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Noble Corporation plc
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
